IRF1 and colorectal cancer: Thirdly, GSEA analysis of transcriptional response in Irf1−/− mutants identifies a highly statistically significant intersection with a human colorectal cancer transcript signature which is absent in B6 controls (Fig. 3D), and this, at an experimental time point where no tumors are present.